pharmathen

Private

Last Round

Buyout/LBO

Jul 19, 2021

Last Round Size

$1.9B

Est. Valuation

$1.9B

Total Funding Raised

$2.43B

Company Overview

Developer and manufacturer of complex generic pharmaceutical products and advanced drug delivery technologies.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare pharmathen with similar companies based on industry and business-model similarity.

No public comparables are available for pharmathen. Request access to learn about comparables coverage.

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	Jul 19, 2021
Buyout/LBO	Jun 3, 2015

Explore SEC and related filing metadata, where available.

pharmathen filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Headquarters—

Year Founded1969

Last FundingJul 19, 2021

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?